Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

184 recalls · Class I, newest first

Class I · High risk

HEPARIN Sodium Injection USP 25

Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-419-02 D-1357-2015
Class I · High risk

HEPARIN Sodium Injection USP

Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-418-02 D-1355-2015
Class I · High risk

5% Dextrose Injection

Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0017-02 D-1209-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-149-50 D-1828-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-236-50 D-1827-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-156-50 D-1826-2015
Class I · High risk

Fentanyl Citrate

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-107-50 D-1825-2015
Class I · High risk

Morphine Sulfate

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-181-50 D-1824-2015
Class I · High risk

Bupivacaine HCl 0.0625%

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-197-50 D-1823-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-169-50 D-1822-2015
Class I · High risk

PHENYLephrine HCl

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Terminated Particulate / foreign matter Pharmedium Services, LLC NDC 61553-171-50 D-1821-2015
Class I · High risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0553-18 D-481-2015

Recalls by year